Latest news with #TheChemoursCompany
Yahoo
16-05-2025
- Business
- Yahoo
Glycolic Acid Market to Reach USD 648.92 million by 2032
Growing demand for biodegradable ingredients and rising preference for chemical exfoliants in anti-aging skincare products are fueling glycolic acid market growth. Austin, May 16, 2025 (GLOBE NEWSWIRE) -- The Glycolic Acid Market Size was valued at USD 349.07 million in 2024 and is expected to reach USD 648.92 million by 2032, growing at a CAGR of 8.06% over the forecast period of PDF Sample of Glycolic Acid Market @ Widening Adoption of Active Ingredients Sparks Momentum in Global Glycolic-Based Skincare Innovations The glycolic acid market is growing at a swift pace due to increasing demand in cosmetics, skin care, and dermatology. Technological advancements have increased their efficiency in acne and aging skin management, and widened their consumer base. Glycolic Acid-infused toiletries saw rising approvals in 2023 as reported by the U.S. FDA, as did domestic production on the part of the EPA. Major players, including The Chemours Company and BASF, declared strategic capacity expansions and product launches from 2022 to 2024, adding to supply. There is greater consumer knowledge of healthy skin and less-invasive procedures, especially in the U.S. and Europe. The consumer demand for natural formulations has further led to the transition to eco-friendly, sugarcane-derived Glycolic Acid. Combined, these trends point to the market's growth and the ingredient's growing presence in upcoming skincare and beauty projects. The US Glycolic Acid Market Size was valued at USD 67.16 million in 2023, projected to reach USD 137.85 million by 2032, growing at a CAGR of 9.41% over the forecast period of 2024-2032. The U.S. Glycolic Acid market is due to the growing consumer awareness regarding the skincare and dermatological benefits of the product. According to the American Academy of Dermatology, Glycolic Acid helps combat acne as well as aging, the same things skincare aspires to do, which is another reason demand is increasing. Nationally ranked U.S. players, such as Ashland and The Chemours Company, have increased production to meet demand, driven by continued growth in domestic consumption and advancements in cosmetic formulation. Key Players: The Chemours Company CABB Group GmbH China Petrochemical Corporation (Sinopec) CrossChem Limited Phibro Animal Health Corporation Avid Organics Pvt. Ltd. Mehul Dye Chem Industries Zhonglan Industry Co., Ltd. Shandong Xinhua Pharmaceutical Co., Ltd. Saanvi Corp Glycolic Acid Market Report Scope: Report Attributes Details Market Size in 2024 USD 349.07 Million Market Size by 2032 USD 648.92 Million CAGR CAGR of 8.06% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Segments • By Grade (Cosmetic Grade, Technical Grade)• By Application (Personal Care & Dermatology, Industrial, Household, Others) Key Drivers • Surging Demand in Skincare and Personal Care Products Drives Market Growth. Buy Full Research Report on Glycolic Acid Market 2025-2032 @ Global Compliance Landscape Governing Safe Use of Glycolic Acid in Consumer Products U.S. Food and Drug Administration has labelled Glycolic Acid as Generally Recognized As Safe (GRAS) when used in the typical cosmetic concentrations of 10% or less. The use of Glycolic Acid in cosmetic products is allowed up to concentrations of 10% for rinse-off products, and up to 5% for leave-on products by the European Commission's SCCS. In South Korea, glycolic acid is subject to use restrictions, which specify permissible concentration and labelling requirements for certain product types, including exfoliant and anti-aging products. The Environmental Protection Agency (EPA) invokes under the Toxic Substances Control Act (TSCA) to control harm such as exposure and safe manufacturing to support the needs for testing and were to gain information. Any product containing Glycolic Acid should also be subjected to dermatological and safety tests to be sold under REACH laws in the EU, so that your skin's well-being is protected. By Grade, the Cosmetic Grade Segment Dominated the Glycolic Acid Market in 2024 with a 67% Market Share This dominance is owed in no small part to the prevalent use of cosmetic-grade Glycolic Acid in skincare, for chemical peels, anti-ageing creams, and acne treatments. Cosmetic grade provides better purity and is required for sensitive skin areas. Large cosmetic companies such as Murad and Paula's Choice have expanded their lines of products with cosmetic-grade Glycolic Acid, resulting in higher demand from consumers. Moreover, the rising dermatological recommendations and FDA approvals for cosmetics further provide impetus to the market. The focus on safe and effective beauty ingredients in the U.S. and Europe also contributes to the growing interest in cosmetic-grade Glycolic Acid as compared to technical grade. By Application, Personal Care & Dermatology Dominated the Glycolic Acid Market in 2024 with a 54% Market Share Glycolic Acid demand in this segment is stimulated by increase in usage in the skin care routine for exfoliation, acne treatment, and anti-aging benefits. Brands such as Neutrogena and Olay introduced new Glycolic Acid products for various skin types making it more accessible. Growing consumer attention toward dermatological health and demand for minimally invasive cosmetic procedures are some other essential factors contributing to the market growth. Additionally, clinical research that demonstrates the effectiveness of Glycolic Acid in personal care has led to greater acceptance. Industrial and end-of-life applications are very critical as well, but rank below personal care owing to the very limited volume usage compared to personal care. Asia Pacific dominated the Glycolic Acid Market in 2024, Holding a 39% Market Share The domination of the region is attributed to the flourishing cosmetics and personal care industry in the region on back of growing disposable income, urbanization, beauty consciousness and changing consumer standards. Major skincare product demand has increased in countries including China, India and South Korea where Glycolic Acid types of skincare products are giving desired results. Factors to it leading the way in the global MRI systems market are the availability of prominent manufacturers and reduced cost of production in the region. Moreover, increase in R&D and product innovation investments in this region drive the market growth and adoption. North America Emerged as the Fastest Growing Region in the Glycolic Acid Market with a Significant Growth Rate in The Forecast Period Positive momentum is generated by strong consumer awareness, significant dermatological research, and stringent regulatory standards for product safety. In the U.S., the market is driven by the introduction of advanced Glycolic Acid delivery systems and formulations for sensitive skin. Prominent players, including Ashland and The Chemours Company, have increased their production and introduced new products in the region. Furthermore, rising consumer interest in non-invasive cosmetic procedures and science-based skincare products contributes to market growth. The robust healthcare infrastructure and higher disposable income in North America also favor this market growth. If You Need Any Customization on Glycolic Acid Market Report, Inquire Now @ Recent Developments March 2025: Brenntag partnered with PureTech to distribute formaldehyde-free Glycolic Acid solutions in North America, targeting clean beauty demand. June 2023: Chemours sold its Glycolic Acid business to PureTech for $137 million to focus on core operations and strategic of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Glycolic Acid Market Segmentation, By Grade 8. Glycolic Acid Market Segmentation, By Application 9. Regional Analysis 10. Company Profiles 11. Use Cases and Best Practice 12. Conclusion Read Our Trending Reports: Bioresorbable Polymers Market Analysis by 2032 Vanillic Acid Market Report Size 2024-2032 Benzoic Acid Market Growth & Future Trends (2024-2032) Oxalic Acid Market - Global Research by 2032 About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Yahoo
07-05-2025
- Business
- Yahoo
The Chemours Company (CC): Among the Best Breakout Stocks to Buy According to Analysts
We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a look at where The Chemours Company (NYSE:CC) stands against other best breakout stocks to buy according to analysts. Stock markets have been on edge in response to the US President's aggressive trade war that has resulted in trade tariffs aimed at settling the trade deficit. Likewise, stocks remain on edge, with the US president ramping up attacks against the Federal Reserve Chair Jerome Powell raising serious concerns about the central bank's independence. Trump has been on Powell's neck over what he terms as laxity in cutting interest rates at a time when major central banks led by the European Central Bank and Bank of Canada have cut significantly. In posts on his social network Trust Social, Trump has always insisted that the US economy would slow unless Powell, who he has always deemed as 'Mr. Too Late, a major loser,' cut rates. The remarks come against the backdrop of major indices pulling back significantly from record highs as stocks remain under pressure across various sectors. The S&P 500 has already closed on the negative for the 3rd straight month, waiting to see if the selloff will persist. The last time the index closed negative for 4 straight months was in 2011. While a negative, the sell-off has presented unique investment opportunities as valuations have pulled back significantly from historical highs. Likewise, the pullback has given rise to solid breakout plays as the selloff dust slowly settles. Nearly two-thirds of the S&P 500 stocks have posted first-quarter 2025 results that have topped estimates. Strong quarterly results from some of the big tech giants are helping alleviate concerns about the potential impact of Trump's tariffs. Likewise, the solid earnings have once again eased concerns that the artificial intelligence progress has slowed amid economic turmoil triggered by the trade war. 'Few stocks are truly immune to Trump tariffs [and] trade war, but AI is a lot less impacted than investors currently believe,' said Jed Ellerbroek, portfolio manager at Argent Capital Management. 'We're early in a very steep growth curve right now, and that goes for AI infrastructure.' China signaling it is evaluating the possibility of starting trade negotiations with the US is a positive for the markets under pressure. The remarks come at a time when the Trump administration is increasingly targeting quick wins with major trading partners. The prospects of a trade agreement between the US and China should be a catalyst to trigger a significant bounce back after months of deep sell-offs.
Yahoo
27-04-2025
- Business
- Yahoo
Is The Chemours Company (NYSE:CC) the Most Promising Small-Cap Stock According to Analysts?
We recently published a list of the 11 Most Promising Small-Cap Stocks According to Analysts. In this article, we are going to take a look at where The Chemours Company (NYSE:CC) stands against other promising small-cap stocks. Robert Teeter of Silvercrest Asset Management recently appeared in an interview to express that he thinks small-cap stocks are currently facing a choppy market, but he also acknowledged that he anticipates a rally later in the year. Based on this sentiment, he advised clients on the importance of diversification within the S&P 500 and pointed to opportunities in international markets. We covered his stance in greater detail in one of our other articles, 10 Best Small-Cap Value Stocks to Buy Now. Here's an excerpt from it: 'He noted that the Trump trade initially boosted small caps due to expectations of economic acceleration and lower interest rates, both of which are favorable for these companies. However, policy uncertainty and weaker-than-expected economic data have delayed their rally. Teeter believes that small caps will come into their own later in the year, but for now, they are facing a choppy market with significant rotation.' However, later on March 26, Villere & Co. Portfolio Manager George Young joined 'Market Domination Overtime' on Yahoo Finance to discuss why investors should be looking at small-cap stocks. George Young stated that small caps currently appear cheap and have been underperforming relative to larger stocks. He highlighted that small-cap stocks have been inexpensive for a while. To support his stance, he pointed out that last year, the S&P 500 rose about 25%, while small-cap stocks increased by only 11%. He explained that this disparity suggests a regression to the mean at some point, which means that the valuation gap between small caps and large caps should eventually narrow. Young also noted a shift in market dynamics during Q1 of this year. While the S&P 500 was down ~2% then, the S&P 500 excluding the MAG7 stocks was actually up ~2%. He described this change as a relatively usual once, since stock market leadership often rotates between sectors and types of stocks. Young particularly favored the small-cap sector when questioned about long-term and steady investments. We sifted through the Finviz stock screener to compile a list of the top small-cap stocks that were trading between $300 million and $2 billion, and that had the highest upside potential (at least 40%). The stocks are ranked in ascending order of their upside potential. We have also added the hedge fund sentiment for each stock, as of Q4 2024, which was sourced from Insider Monkey's database. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here). A technician performing quality checks on a range of specialty chemicals. Market Capitalization as of April 23: $1.78 billion Number of Hedge Fund Holders: 40 Average Upside Potential as of April 23: 59.53% The Chemours Company (NYSE:CC) provides performance chemicals internationally. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The company's Thermal & Specialized Solutions (TSS) segment produces and sells refrigerants. The Opteon Refrigerants are a key product line in this segment and are designed to replace older and environmentally harmful refrigerants with more sustainable alternatives. In Q4 2024, TSS net sales hit a record $390 million, which was a 3% improvement year-over-year. Opteon sales alone surged 23%. The company expanded Opteon capacity at Corpus Christi by 40%, with half available in 2025 and the rest in 2026. This supports Chemours' anticipated double-digit Opteon growth in 2025. However, BMO Capital analyst John McNulty recently reduced his price target for The Chemours Company (NYSE:CC) from $34 to $27 while maintaining an Outperform rating due to the company's weaker-than-expected Q4 earnings and outlook. The analyst thinks that the company may experience a slow start in Q1 2025. Buckley Capital sees strong growth and high-profit potential in the company's TSS division due to its environmentally friendly, high-margin Opteon product. It stated the following regarding Chemours Co. (NYSE:CC) in its Q3 2024 investor letter: The Chemours Company (NYSE:CC) is an investment we have owned since 2018, very profitably until this year. It is composed of 3 different businesses – TSS, APM, and TT – that are each the #1 or #2 players in their respective categories. Overall, CC ranks 8th on our list of the most promising small-cap stocks according to analysts. While we acknowledge the growth potential of CC, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than CC but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
26-03-2025
- Business
- Yahoo
The Chemours Company (NYSE:CC) Delivered A Better ROE Than Its Industry
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. To keep the lesson grounded in practicality, we'll use ROE to better understand The Chemours Company (NYSE:CC). ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Chemours is: 14% = US$86m ÷ US$605m (Based on the trailing twelve months to December 2024). The 'return' is the yearly profit. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.14 in profit. View our latest analysis for Chemours By comparing a company's ROE with its industry average, we can get a quick measure of how good it is. However, this method is only useful as a rough check, because companies do differ quite a bit within the same industry classification. Pleasingly, Chemours has a superior ROE than the average (9.9%) in the Chemicals industry. That is a good sign. With that said, a high ROE doesn't always indicate high profitability. Aside from changes in net income, a high ROE can also be the outcome of high debt relative to equity, which indicates risk. To know the 3 risks we have identified for Chemours visit our risks dashboard for free. Companies usually need to invest money to grow their profits. That cash can come from issuing shares, retained earnings, or debt. In the case of the first and second options, the ROE will reflect this use of cash, for growth. In the latter case, the debt used for growth will improve returns, but won't affect the total equity. Thus the use of debt can improve ROE, albeit along with extra risk in the case of stormy weather, metaphorically speaking. We think Chemours uses a significant amount of debt to maximize its returns, as it has a significantly higher debt to equity ratio of 6.71. Its ROE is decent, but once I consider all the debt, I'm not really impressed. Return on equity is a useful indicator of the ability of a business to generate profits and return them to shareholders. In our books, the highest quality companies have high return on equity, despite low debt. If two companies have the same ROE, then I would generally prefer the one with less debt. But when a business is high quality, the market often bids it up to a price that reflects this. Profit growth rates, versus the expectations reflected in the price of the stock, are a particularly important to consider. So you might want to take a peek at this data-rich interactive graph of forecasts for the company. If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Associated Press
18-03-2025
- Business
- Associated Press
Chemours and Energy Fuels Forming Strategic Alliance to Create a Domestic Supply Chain of Critical Minerals for the United States
The Chemours Company (NYSE: CC) and Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), today announced they are forming a strategic alliance to expand the companies' existing relationship to enhance U.S. domestic rare earth and critical mineral supply chains to meet increasing demand. The alliance will capitalize on the complementary geographic and operational synergies of both organizations. Energy Fuels, a leading U.S. producer of rare earth elements, is currently developing new heavy mineral sands projects in Madagascar, Brazil, and Australia, expected to produce world-scale quantities of rare earth, titanium ilmenite and zircon minerals in the coming years. Chemours mines and separates heavy mineral sands from its mines in Florida and Georgia. 'Chemours is proud to play a role in strengthening U.S. critical and rare earth mineral supply. This is a transformative time in our industry, and we are fortunate to have found a likeminded U.S. partner in Energy Fuels for this important work,' said Damián Gumpel, President of Chemours Titanium Technologies. 'Energy Fuels and Chemours each have unique, complementary capabilities, which can be deployed to solve many of America's critical mineral supply chain challenges in rare earth elements, titanium and zirconium. Energy Fuels and Chemours have collaborated successfully over the past four years, and we look forward to expanding our relationship in this key area,' said Mark Chalmers, President and CEO of Energy Fuels. Rich Nolan, President and CEO of the National Mining Association applauded the news saying, 'Today's announcement is a prime example of the mining industry's desire to help drive the reshoring of our mineral supply chains and ramp up domestic production to meet the massive mineral demands of modern society. Secure supply chains begin at home—where we do things in accordance with the world's highest environmental, labor and safety standards.' Chairman Mike Lee (R-UT) shared, 'America's economic and national security depends on a strong, domestic supply chain for critical minerals. This agreement is a major step toward securing that supply, ensuring that rare earth elements, titanium, and zirconium are sourced and processed here at home. By combining their strengths, these two companies are reinforcing America's industrial base and reducing our reliance on foreign adversaries for materials essential to energy, defense, and advanced manufacturing.' 'The United States cannot rely on our adversaries for the natural resources essential to our economy and national security. We should be leading the way in producing critical minerals—after all, we do it better and cleaner than anywhere else,' said Senator John Curtis (R-UT). 'I applaud Energy Fuels and Chemours on their strategic alliance to strengthen America's domestic critical mineral supply chain. This partnership will directly support the White Mesa Mill in Utah—strengthening our economy and reinforcing Utah's role in national security.' 'For the United States to remain competitive, it's important to bolster domestic supply chains of critical minerals, as well as onshoring minerals from around the globe to be processed and utilized here,' said Rep. Kat Cammack (R-FL). 'I'm grateful to Chemours and their partners for working together to continue developing the most advanced critical mineral supply in the U.S.' About The Chemours Company The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 6,000 employees and 28 manufacturing sites and serves approximately 2,500 customers in approximately 110 countries. For more information, visit or follow us on X (formerly Twitter) @Chemours or LinkedIn. Forward-Looking Statements This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words 'believe,' 'expect,' 'will,' 'anticipate,' 'plan,' 'estimate,' 'target,' 'project' and similar expressions, among others, generally identify 'forward-looking statements,' which speak only as of the date such statements were made. These forward-looking statements may address, among other things, partnerships or potential partnerships with third-party companies, new mining operations, the ability to supply or support onshoring critical minerals, plans to expand partnerships, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions and global health events, and changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2024. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law. Brandon Ontjes VP, Head of Strategy & Investor Relations +1.302.773.3300 [email protected] NEWS MEDIA Cassie Olszewski Media Relations & Reputation Leader +1.302.219.7140 [email protected] KEYWORD: UNITED STATES NORTH AMERICA DELAWARE COLORADO INDUSTRY KEYWORD: OTHER MANUFACTURING ENGINEERING TRANSPORT CHEMICALS/PLASTICS HVAC MANUFACTURING MINING/MINERALS LOGISTICS/SUPPLY CHAIN MANAGEMENT NATURAL RESOURCES SOURCE: The Chemours Company Copyright Business Wire 2025. PUB: 03/18/2025 06:15 AM/DISC: 03/18/2025 06:14 AM
